UPDATED Apr 29, 2024
Well rounded companies, with acceptable leverage, projected to deliver an ROE north of 20% in three years.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
2330 | NT$790.00 | 4.8% | 57.7% | NT$20.5t | NT$912.98 | PE23.9x | E16.1% | 1.8% | Semiconductors | ||
AZN | UK£120.62 | 7.0% | 2.4% | UK£186.4b | UK£131.45 | PE37x | E16.6% | 2.0% | Pharmaceuticals & Biotech | ||
NOVN | CHF89.05 | 0.1% | -3.4% | CHF181.3b | CHF98.87 | PE21.9x | E10.1% | 3.7% | Pharmaceuticals & Biotech | ||
ROG | CHF220.60 | -4.0% | -21.4% | CHF178.5b | CHF279.06 | PE15.3x | E8.8% | 4.4% | Pharmaceuticals & Biotech | ||
SAF | €204.20 | -2.3% | 47.1% | €84.7b | €210.37 | PE24.5x | E7.1% | 1.1% | Capital Goods | ||
SLB | US$49.21 | -0.6% | 0.1% | US$70.3b | US$67.17 | PE16.2x | E15.4% | 2.2% | Energy | ||
ZURN | CHF444.20 | -2.1% | 4.5% | CHF64.0b | CHF462.08 | PE16.1x | E8.9% | 5.8% | Insurance | ||
NTES | US$96.63 | 1.8% | 8.5% | US$61.9b | US$132.85 | PE15.3x | E7.9% | 2.6% | Media | ||
300760 | CN¥304.59 | 7.1% | -2.3% | CN¥368.4b | CN¥396.08 | PE30.3x | E14.9% | 1.9% | Healthcare | ||
2454 | NT$992.00 | 2.1% | 47.8% | NT$1.6t | NT$1,195.10 | PE20.5x | E13.3% | 6.1% | Semiconductors | ||
BBRI | Rp4,940.00 | -6.8% | -4.1% | Rp719.3t | Rp6,397.17 | PB2.5x | E10.6% | 6.5% | Banks | ||
BMRI | Rp6,900.00 | 1.1% | 31.4% | Rp646.3t | Rp7,595.48 | PB2.5x | E9.4% | 5.1% | Banks | ||
2020 | HK$89.70 | 2.8% | -4.6% | HK$254.1b | HK$112.00 | PE23x | E12.9% | 2.6% | Consumer Durables | ||
EVO | kr1,232.00 | -7.6% | -4.8% | kr258.4b | kr1,487.77 | PE20.3x | E12.5% | 2.5% | Consumer Services | ||
300274 | CN¥103.35 | 6.6% | -8.3% | CN¥151.8b | CN¥130.67 | PE15.1x | E11.2% | 0.9% | Capital Goods | ||
NESTE | €21.34 | -18.6% | -50.8% | €16.6b | €33.80 | PE12.1x | E15.5% | 5.6% | Energy | ||
KCHOL | ₺226.10 | 4.7% | 205.5% | ₺570.6b | ₺215.07 | PE7.9x | E26.5% | 3.5% | Capital Goods | ||
SOON | CHF255.40 | 0.08% | -8.2% | CHF15.4b | CHF270.88 | PE25.4x | E10.7% | 1.8% | Healthcare | ||
ALL | AU$39.92 | -3.3% | 5.6% | AU$25.3b | AU$47.49 | PE17.4x | E5.1% | 1.7% | Consumer Services | ||
JMT | €19.35 | 2.5% | -15.5% | €12.2b | €23.51 | PE17.1x | E8.6% | 3.4% | Consumer Retailing | ||
300122 | CN¥35.10 | -0.8% | -35.3% | CN¥84.0b | CN¥62.47 | PE11.2x | E22.8% | 2.3% | Pharmaceuticals & Biotech | ||
600845 | CN¥41.03 | 11.2% | -8.8% | CN¥83.2b | CN¥49.57 | PE37.3x | E21.4% | 2.4% | Software | ||
ALV | US$121.24 | 3.4% | 41.7% | US$10.0b | US$129.91 | PE18.3x | E16.8% | 2.2% | Automobiles | ||
DOX | US$84.87 | -1.7% | -8.3% | US$9.9b | US$104.90 | PE17.7x | E15.8% | 2.3% | Software |